medline.ch Onkologie Urologische Tumoren

	Real-world Data to Assess the Applicability of Randomized Controlled Trials in Newly Metastatic Prostate Cancer. Eur Urol Focus Gandaglia G, Pellegrino F, Hijazy A, Meulder B, Abbott T, Golozar A, de Angelis M, Nicoletti R, Rajwa P, Rivas JG, Steinbeisser C, Papineni KR, Roggenkamp T, Kotik D, Victor T, Evans-Axelsson S, Briganti A, N'Dow J. PMID: 42919757 [PubMed - as supplied by publisher]
	Epidemiology, Risk Factors, and Prevention of Prostate Cancer. Eur Urol Gandaglia G, Weiner AB, Briganti A, Eeles RA, Eggener S, Gleave M, Graefen M, La Vecchia C, Mignozzi S, Stattin P, Hayes V, van Poppel H, Albers P. PMID: 42919739 [PubMed - as supplied by publisher]
	TheraPb Phase 1b: First-in-Human Dose-Escalation and Optimization Study of (212)Pb-ADVC001 in PSMA-Positive Metastatic Androgen Pathway Modulation-Resistant Prostate Cancer. J Nucl Med Hansen AR, Pattison DA, Goh JC, Ngai SS, Ravi Kumar AS, Gan CL, Kuchel A, Mason RB, Katchel L, Campbell L, Brady J, Papa N, Santoro PM, Crumbaker MA, Baronet MC, Karmann AM, Wyld DK. PMID: 42919672 [PubMed - as supplied by publisher]
	PSA testing and receipt of curative treatment in elderly Japanese men with prostate cancer: a population-based study. BMC Urol Tobu S, Takahashi H, Isoda H, Fujimoto K, Noguchi M. PMID: 42919289 [PubMed - indexed for MEDLINE]
	Evaluating Gates' GFR accuracy in renal tumor patients through integration of standalone CT-derived renal depth estimation via deep learning segmentation: a preliminary study. BMC Nephrol Wu C, Chen G, Liao Q, Zhang F, Xie L, Zha Y. PMID: 42919248 [PubMed - indexed for MEDLINE]
	Effect of data-driven gating on the quantification of prostate cancer metastases in (68)Ga-PSMA- and Â¹â¸F-DCFPyL-PSMA PET/CT. EJNMMI Rep Farag A, Felder C, Hussey D, Mirshahvalad SA, Harsini S, Metser U, Veit-Haibach P. PMID: 42918964 [PubMed]
	Federated Learning-Based Multi-Task Framework for Privacy-Preserving Diagnosis of Muscle Invasion in Bladder Cancer. J Imaging Inform Med Zhang Z, Cao K, Li J, He Z, Zhang J, Wang G, Zhang W, Song W, Huang B. PMID: 42918947 [PubMed - as supplied by publisher]
	Capivasertib plus abiraterone in PTEN-deficient de novo metastatic hormone-sensitive prostate cancer: updated survival analysis from CAPItello-281. Ann Oncol Fizazi K, Clarke NW, De Santis M, Uemura H, Fay AP, Karadurmus N, Alvarez-Fernandez C, Jiang S, Parslow D, Sotelo M, Ürün Y, Oliveira N, Gyun Kwon T, Özgüro, Roubaud G, Castellano D, Logan JK, Morris T, Gresty C, George DJ. PMID: 42918424 [PubMed - as supplied by publisher]
	Perioperative pembrolizumab or placebo plus neoadjuvant cisplatin and gemcitabine in participants with muscle-invasive bladder cancer who are eligible for cisplatin: the double-blind, phase III KEYNOTE-866 study. Ann Oncol Bedke J, Arkosy P, Nishiyama H, Mahammedi H, Vulsteke C, Juan-Fita MJ, Antonyan I, Didas O, Verzoni E, Atduev V, Rodriguez-Vida A, Oh JJ, Kang SH, Peer A, Zukov R, Zurawksi B, Gümü, Steinberg GD, Olah J, Abadie-Lacourtoisie S, Jain N, Franco S, Moreno BH, Hoimes CJ, Siefker-Radtke A. PMID: 42918422 [PubMed - as supplied by publisher]
	Neoadjuvant nivolumab plus gemcitabine-cisplatin followed by postsurgical adjuvant nivolumab versus neoadjuvant gemcitabine-cisplatin in patients with muscle-invasive bladder cancer: final results from the phase III CA017-078 trial. Ann Oncol Sonpavde G, van der Heijden MS, Gupta S, Galsky MD, Steinberg G, Gschwend JE, Sade JP, Bimbatti D, De Giorgi U, Schepisi G, Estévez SV, Panay S, Schinzari G, Kotsakis A, Miyake H, Oh JJ, Zhang J, Jeyamohan C, Neely J, Jacques M, Duong Q, Sarkar S, Necchi A. PMID: 42918420 [PubMed - as supplied by publisher]
	"Imaging Triplets on Two Wheels": 61Cu-, 64Cu-, and 68Ga-labeled Bicyclic Peptides Targeting Nectin-4 Enable High-Contrast PET Imaging of Urothelial Carcinoma and Triple-Negative Breast Cancer. Bioconjug Chem Mauersberger J, Krönke T, Ullrich M, Laube M, Brandt F, Pretze M, Lohaus F, Hoberück S, Thomas C, Miederer M, Bundschuh RA, Stadlbauer S, Kopka K, Pietzsch J, Wodtke R. PMID: 42915462 [PubMed - indexed for MEDLINE]
	Molecular features of prostate cancer with neuroendocrine differentiation. Semin Diagn Pathol Nezami BG, Lin X. PMID: 42914592 [PubMed - as supplied by publisher]
	Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with renal cell carcinoma. ESMO Open Kanesvaran R, Gruenwald V, Wong A, Chan J, Yaoi X, Mulansari NA, Sahoo TP, Miura Y, Kim H, Saad M, Talag-Espinosa M, Su YL, Chansriwong P, Charoentum C, Tsai YC, Lola C, Thiagarajan M, Park SH, Kondoh C, Shaikh I, Hamid ARAH, Zhou F, Trapani D, Lim E, Ang D, Chong TW, Poon E, Schmidinger M. PMID: 42914499 [PubMed - indexed for MEDLINE]
	Succinate dehydrogenase-deficient renal cell carcinoma: clinicopathological correlation and diagnostic insights. BMJ Case Rep Dayasagar H, Kumar H, John NT. PMID: 42914194 [PubMed - in process]
	N-(3-Trifluoromethylphenyl)sulfonyl-indole-3-carbaldehyde thiosemicarbazones induce apoptosis and modulate p53-associated signaling in prostate cancer: integrated experimental and computational studies. Chem Biol Interact Kubra KT, Acar ÖÖ, , , , Batool K, Albekairi NA, Rasool A, Shafiq Z, Alshammari A. PMID: 42914071 [PubMed - as supplied by publisher]
	Francophone Expert Consensus on Onco-Sexological Care for Prostate Cancer. Fr J Urol Huyghe E, Bondil P, Fiard G, Methorst C, Schoentgen N, Burte C. PMID: 42914056 [PubMed - as supplied by publisher]
	Comparison of oral 5-aminolevulinic acid-induced hypotension between general and spinal anesthesia during photodynamic diagnosis-assisted transurethral resection of bladder tumor for non-muscle invasive bladder cancer. Photodiagnosis Photodyn Ther Fukuhara H, Shigehisa R, Yamamoto S, Fukata S, Saito K, Kamiya A, Shibanaka Y, Koga K, Inoue K. PMID: 42913819 [PubMed - as supplied by publisher]
	Cancer outcomes in patients with high- and very-high-risk prostate cancer following radical prostatectomy. Cir Cir Hernández-Gaytán CA, Alcacio-Mendoza J, González-Chavira J, Feria-Bernal G, Gabilondo-Pliego B, Castillejos-Molina R, Rodríguez-Covarrubias F. PMID: 42913621 [PubMed - indexed for MEDLINE]
	Body mass index at diagnosis, postdiagnosis change, and role of metabolic comorbidities in relation to survival in nonmetastatic renal cell carcinoma patients. Cancer Sarker M, Deng Z, Kauffman EC, Tang L, Kwan ML, Langston ME, Gupta S, Grass GD, Singer EA, Zakharia Y, Viscuse PV, Graham L, Ghodoussipour S, Salhia B, Kern SQ, Ayanambakkam A, Myint Z, King J, Oderinde S, Churchman ML, Rounbehler RJ, Batai K. PMID: 42913421 [PubMed - indexed for MEDLINE]
	Monthly high-dose cholecalciferol supplementation in prostate cancer patients (ProsD trial): A nested analysis of vitamin D metabolites, metabolic ratios, and biochemical safety. Cancer Epidemiol Tan C, David MC, Anderson PH, Mason RS, Fraser DR, Kimlin MG, Sawyer RK, Amirmostofian M, Frydenberg M, Yaxley JW, Gillatt D, Woo H, Rashid P, Gardiner R', Rasiah K, Patel MI, Gurney H, Smith DP, Nair-Shalliker V. PMID: 42913061 [PubMed - as supplied by publisher]

Artikel 1 - 20 / 182389

Seite 1 von 9120

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

Übersetzungsproblem?

mehr >>



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung